Royal Bank of Canada’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.85M | Buy |
185,760
+184,051
| +10,770% | +$1.83M | ﹤0.01% | 3089 |
|
|
2025
Q1 | $10K | Sell |
1,709
-1,698
| -50% | -$9.94K | ﹤0.01% | 5770 |
|
|
2024
Q4 | $26K | Buy |
3,407
+647
| +23% | +$4.94K | ﹤0.01% | 5508 |
|
|
2024
Q3 | $28K | Buy |
2,760
+318
| +13% | +$3.23K | ﹤0.01% | 5512 |
|
|
2024
Q2 | $36K | Buy |
2,442
+1,045
| +75% | +$15.4K | ﹤0.01% | 5410 |
|
|
2024
Q1 | $19K | Sell |
1,397
-5,552
| -80% | -$75.5K | ﹤0.01% | 5499 |
|
|
2023
Q4 | $76K | Buy |
6,949
+2,788
| +67% | +$30.5K | ﹤0.01% | 5239 |
|
|
2023
Q3 | $46K | Buy |
4,161
+1,575
| +61% | +$17.4K | ﹤0.01% | 5340 |
|
|
2023
Q2 | $34K | Buy |
2,586
+1,255
| +94% | +$16.5K | ﹤0.01% | 5502 |
|
|
2023
Q1 | $18K | Sell |
1,331
-1,369
| -51% | -$18.5K | ﹤0.01% | 5676 |
|
|
2022
Q4 | $53K | Buy |
2,700
+2,395
| +785% | +$47K | ﹤0.01% | 5371 |
|
|
2022
Q3 | $5K | Buy |
305
+136
| +80% | +$2.23K | ﹤0.01% | 6239 |
|
|
2022
Q2 | $4K | Sell |
169
-1,077
| -86% | -$25.5K | ﹤0.01% | 6257 |
|
|
2022
Q1 | $40K | Sell |
1,246
-2,166
| -63% | -$69.5K | ﹤0.01% | 5754 |
|
|
2021
Q4 | $158K | Buy |
3,412
+1,248
| +58% | +$57.8K | ﹤0.01% | 5047 |
|
|
2021
Q3 | $59K | Sell |
2,164
-310
| -13% | -$8.45K | ﹤0.01% | 5551 |
|
|
2021
Q2 | $63K | Buy |
2,474
+742
| +43% | +$18.9K | ﹤0.01% | 5391 |
|
|
2021
Q1 | $59K | Buy |
1,732
+1,458
| +532% | +$49.7K | ﹤0.01% | 5295 |
|
|
2020
Q4 | $9K | Buy |
+274
| New | +$9K | ﹤0.01% | 5873 |
|